NCT07122401: Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
- State
- Under way
- Phase
- Phase 3
- People
- 424 planned
- Started
- 30 Sep 2025
- Primary completion
- 26 Nov 2026
- Arms
- MT1013
- Results
- None posted
- 14 Aug 2025: Trial registered
- 30 Sep 2025: Trial started